Srinivas Rao Kasibhatla

This inventor holds 26 USPTO granted patents and 10 published patent applications and 3 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Metabasis Therapeutics, Inc., Conforma Therapeutics Corporation, Stingray Therapeutics, Inc.. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srinivas Rao Kasibhatla. Retrieved from https://idiyas.com/inventor/srinivas-rao-kasibhatla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 10)

% Patents Active = 88.5

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 5.0

ph-index = 12

Forward Citations = 532(Granted Patents)

Location History:

Houston, TX (US) (2022)
San Diego, CA (US) (1998 - 2023)

Company Filing History:

9 out of 64

Metabasis Therapeutics, Inc.

patents

8 out of 10

Conforma Therapeutics Corporation

patents

4 out of 7

Stingray Therapeutics, Inc.

patents

4. 2 out of 3

Beta Cat Pharmaceuticals, Inc.

Sankyo Company, Limited

patents

7. 1 out of 834,513

Other

patents

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

HSP90 Inhibitors

ENPP1 Inhibitors

Fibrotic Diseases

Purine Analog

Anthracene Compounds

Phosphonate Prodrugs

Pyrrolopyrimidines

Indole Inhibitors

Benzimidazole Compounds

Fructose-1,6-Bisphosphatase

Adenosine Monophosphate Deaminase

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12741963 - Imidazole compounds as inhibitors of ENPP1 (2026-09-22),

2. 12653835 - Phosphonates as inhibitors of ENPP1 and CDNP (2026-06-16),

3. 12152015 - Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof (2024-11-26),

4. 11591313 - Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof (2023-02-28),

5. 11298346 - Methods for treatment of fibrotic diseases (2022-04-12),

6. 9963475 - Anthracene-9, 10-dione dioxime compound prodrugs and their uses (2018-05-08),

7. 9725473 - Anthracene-9, 10-dione dioxime compound prodrugs and their uses (2017-08-08),

8. 8093229 - Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors (2012-01-10),

9. 7553979 - HSP90-inhibiting zearalanol compounds and methods of producing and using same (2009-06-30),

10. 7544672 - Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors (2009-06-09),

11. 7312219 - Heteroaromatic inhibitors of fructose 1,6-bisphosphatase (2007-12-25),

12. 7285543 - Purine inhibitors of fructose-1,6-bisphosphatase (2007-10-23),

13. 7241890 - Purine analogs having HSP90-inhibiting activity (2007-07-10),

14. 7148228 - Pyrazolopyrimidines and related analogs as HSP90-inhibitors (2006-12-12),

15. 7138402 - Pyrrolopyrimidines and related analogs as HSP90-inhibitors (2006-11-21),

Title: Inventor Srinivas Rao Kasibhatla

Introduction: Srinivas Rao Kasibhatla is a prolific inventor based in San Diego, CA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Srinivas Rao Kasibhatla holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With over two decades of experience in research and development, Kasibhatla has worked with leading tech companies, universities, and research institutions to bring cutting-edge ideas to life. His innovative solutions have significantly impacted industries worldwide.

Collaborations: Throughout his career, Srinivas Rao Kasibhatla has collaborated with top engineers, scientists, and designers to create revolutionary products and technologies. His ability to work in multidisciplinary teams has led to the successful implementation of numerous projects.

Conclusion: In conclusion, Srinivas Rao Kasibhatla's passion for innovation and his relentless drive to push the boundaries of technology make him a standout figure in the world of inventors. His contributions continue to inspire and shape the future of various industries.

Profile summary based on public USPTO records.